74 results on '"Zeitouni, Michel"'
Search Results
2. Immediate Microvascular Physiology After Mechanical Coronary Reperfusion of STEMI
3. Takotsubo syndrome : A cause of reversible microvascular coronary dysfunction
4. Bioprosthetic leaflet thrombosis and reduced leaflet motion after transcatheter aortic valve replacement: A systematic review and meta-analysis
5. Comparison of three echo-guidance techniques in percutaneous patent foramen ovale closure for stroke prevention: Conventional transoesophageal, microprobe transoesophageal and intracardiac echocardiography
6. P2Y12 inhibitor loading time before elective PCI and the prevention of myocardial necrosis
7. Phenotyping Coronary Plaque by Computed Tomography in Premature Coronary Artery Disease
8. Understanding Myocardial Infarction in Young Individuals Now or in 30 Years?
9. Reply
10. Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials
11. Reply
12. De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?
13. Beta-blocker prescription and outcomes in uncomplicated acute myocardial infarction: Insight from the ePARIS registry
14. Supraventricular Arrhythmia Following Patent Foramen Ovale Percutaneous Closure
15. Prevention and treatment of premature ischaemic heart disease with European Society of Cardiology Guidelines
16. Mechanisms and Definitions of Periprocedural Myocardial Infarction in the Era of Modern Revascularization
17. Heparin pretreatment in STEMI: is earlier always better?
18. Association Between Peripheral Versus Central Access for Alternative Access Transcatheter Aortic Valve Replacement and Mortality and Stroke: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry
19. Outcomes Following Patent Foramen Ovale Percutaneous Closure According to the Delay From Last Ischemic Event
20. Prophylactic Mechanical Circulatory Support Use in Elective Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease
21. ESC/EAS guidelines for the detection, prevention, and treatment of individuals at risk of a first myocardial infarction: effect of 5 years of updates and the new SCORE2
22. Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial
23. Ten-Year Trends in Patient Characteristics, Treatments, and Outcomes in Myocardial Infarction From National Cardiovascular Data Registry Chest Pain–MI Registry
24. Appropriate criteria for the definition of Type 4a MI
25. Pretreatment in the Setting of Non–ST-Elevated Acute Coronary Syndrome—When It Is Time to Change
26. Altered cardiac reserve is a determinant of exercise intolerance in sickle cell anaemia patients
27. Culprit lesion location and outcomes in patients with multivessel disease and infarct-related cardiogenic shock: a core laboratory analysis of the CULPRIT-SHOCK trial
28. Beyond ischaemia: is there a place for physiologic and anatomic evaluations of coronary lesions?
29. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
30. ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France
31. Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis
32. Aspirin-Free Strategies in ACS
33. Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trial
34. Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units
35. Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy
36. Single Versus Dual Antiplatelet Therapy Following TAVR
37. Precision Medicine in TAVR: How to Select the Right Device for the Right Patient
38. Predictive Value of the Residual SYNTAX Score in Patients With Cardiogenic Shock
39. Risk Factor Burden and Long‐Term Prognosis of Patients With Premature Coronary Artery Disease
40. Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data
41. Abstract 12886: Ten-year Trends in Patient Characteristics, Treatments, and Outcomes in St Elevation Mi Patients in the Us - A Report From NCDR CP-MI Registry
42. Resting Coronary Physiology in Stable Coronary Artery Disease
43. Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial
44. Interleukin-1β and Risk of Premature Death in Patients With Myocardial Infarction
45. Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults
46. 2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations
47. Reply
48. Catheterization Laboratory Activation Time in Patients Transferred With ST-Segment–Elevation Myocardial Infarction: Insights From the Mission: Lifeline STEMI Accelerator-2 Project
49. Acute Multivessel Coronary Occlusion Revealing COVID-19 in a Young Adult
50. Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.